stockrowAlector, Inc. (ALEC) vs C4 Therapeutics, Inc. (CCCC)
- Alector, Inc. ALEC 2.47 −6.08%
- C4 Therapeutics, Inc. CCCC 2.79 −3.46%
Alector, Inc. and C4 Therapeutics, Inc. are both Biotechnology companies. Alector, Inc. and C4 Therapeutics, Inc. are of similar size ($391.6M and $379.5M). C4 Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 7.5×. Alector, Inc. grew revenue faster over the last twelve months: 151.2% against 7.20%. Alector, Inc. has the higher net margin (23.9% vs −282.2%) and the higher return on invested capital (0.00% vs −279.8%). Across the 16 metrics below, Alector, Inc. leads on 11 and C4 Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ALEC | CCCC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.81% |
| Operating margin | 20.16% | (315.86%) | 0.00% |
| Net margin | 23.87% | (282.22%) | 0.00% |
| Free cash flow margin | (86.31%) | (247.05%) | 0.00% |
| Return on equity | 47.52% | (47.62%) | (50.30%) |
| Return on assets | 16.53% | (30.50%) | (45.47%) |
| Return on invested capital | 0.00% | (279.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack